Age: 34.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood test, Chest pain, Dyspnoea, Gait disturbance, Inflammation
Clinical narrative: Chest pain; tachycardia; dyspnea; Scans and blood tests are showing inflammation; unable to do more than a slow walk; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 35-year-old male patient received BNT162b2 (BNT162B2), on 16Dec2021 at 09:30 as dose 3 (booster), single (Lot number: FD0809) at the age of 34 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: Penicillin" (unspecified if ongoing); "Known allergies: cephalosporins" (unspecified if ongoing). There were no concomitant medications. Vaccination history included: BNT162b2 (Previous dose details:, Prev dose product=COVID 19, Prev dose brand=Pfizer, Prev dose brand unknown=False, Prev dose administration date: 27Apr2021, Prev dose administration time: 09:30 AM, Prev dose lot number=ER8732, Prev dose dose number=2, Prev dose vaccine location=Left arm), administration date: 27Apr2021, when the patient was 34-year-old, for COVID-19 immunization; BNT162b2 (Prev dose product=COVID 19, Prev dose brand=Pfizer, Prev dose brand unknown=False, Prev dose administration date: 05Apr2021, Prev dose administration time: 09:30 AM, Prev dose lot number=ER8729, Prev dose dose number=1, Prev dose vaccine location=Left arm), administration date: 05Apr2021, when the patient was 34-year-old, for COVID-19 immunization. The following information was reported: CHEST PAIN (hospitalization) with onset 16Dec2021 at 18:00, outcome "not recovered"; INFLAMMATION (hospitalization) with onset 16Dec2021 at 18:00, outcome "not recovered", described as "Scans and blood tests are showing inflammation"; DYSPNOEA (hospitalization) with onset 16Dec2021 at 18:00, outcome "not recovered", described as "dyspnea"; TACHYCARDIA (hospitalization) with onset 16Dec2021 at 18:00, outcome "not recovered"; GAIT DISTURBANCE (hospitalization) with onset 16Dec2021 at 18:00, outcome "not recovered", described as "unable to do more than a slow walk". The patient was hospitalized for chest pain, tachycardia, dyspnoea, inflammation, gait disturbance (hospitalization duration: 6 day(s)). The events "chest pain", "tachycardia", "dyspnea", "scans and blood tests are showing inflammation" and "unable to do more than a slow walk" required physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: Blood test: (16Dec2021) inflammation, notes: Scans and blood tests are showing inflammation; SARS-CoV-2 test: (Jan2022) Negative, notes: Nasal Swab; (Feb2022) Negative, notes: Nasal Swab; (Mar2022) Negative, notes: Nasal Swab; (Apr2022) Negative, notes: Nasal Swab; (May2022) Negative, notes: Nasal Swab; Scan: (16Dec2021) inflammation. Therapeutic measures were taken as a result of chest pain, tachycardia, dyspnoea, inflammation, gait disturbance.  Clinical course: As reported no other vaccine in four weeks and no medication in two weeks was administered to patient. Facility type for vaccine was Pharmacy or drug store. He was an active 35 year old male who does a lot of running and cycling, but had been unable to do more than a slow walk since receiving the vaccine. Symptoms began hours after receiving the booster shot. The treatment was given in form of fluids and medications. No covid prior to vaccination.  No follow-up attempts are possible. No further information is expected.